Leading clinicians from around the world will present the most recent clinical and scientific advances affecting the field of liver transplantation. They will focus on three areas: i. Management advances in hepatobiliary malignancies, particularly hepatocellular carcinoma and cholangiocarcinoma ii.
Research Oral Presentations Only
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 866 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1553-5592
- DOI
- 10.1002/jhm.706
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This course will present the current challenges and advances in immunosuppressive therapy in the field of liver transplantation. It will focus on three separate areas: i.Overview of current issues in maintenance and induction therapy. ii.Immunosuppression tailored to specific diseases, including im
The right 3D-conformation of a peptide, is essential for its biological activity. Nature has found many elegant ways to reduce the flexibility of peptides/proteins in order to control their folding and shape for increasing affinity as well as selectivity for receptor interaction. Disulfide bridges,
Hepatitis C virus (HCV) infection is the leading cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. It has been estimated that 3% of the world population is infected with this virus and the current available treatments are of limited efficacy. One of the most intensively stud
Enhancement of Bone Marrow Uptake of Nitroxide Contrast Agents for MRI. A Study Using Liposome Entrapped CAT-1 after Liver Blockade.